Tuberculosis remains one of the main causes of death worldwide. The long and cumbersome process of culturing Mycobacterium tuberculosis complex (MTBC) bacteria has encouraged the development of specific molecular tools for detecting the pathogen. Most of these tools aim to become novel tuberculosis diagnostics, and big efforts and resources are invested in their development, looking for the endorsement of the main public health agencies. Surprisingly, no study had been conducted where the vast amount of genomic data available is used to identify the best MTBC diagnostic markers. In this work, we use large-scale comparative genomics to provide a catalog of 30 characterized loci that are unique to the MTBC.
Several other genes have been used as markers for the accurate identification of MTBC bacteria [18] [19] [20] [21] . However, the accuracy of NAATs based on these markers rely on the specificity of the primers, since most of the targeted loci are claimed to be MTBC-specific, yet they were evaluated with limited genomic information on the diversity of NTM and MTBC bacteria.
Nowadays, the use of the publicly available omic data can help identifying speciesspecific genetic markers to develop accurate molecular tools. Analyzing omic data has been proven to be an effective strategy for the identification of specific markers in several organisms [22] [23] [24] [25] [26] , and even some workflows have been published for the evaluation of genetic markers based on genomic data [27] . For instance, comparative genomics was used by Zozaya-Valdés et al. to assess the population structure of Mycobacterium chimaera, identifying six specific loci of these organisms that allowed them to develop a highly accurate qPCR assay.
Strikingly, the use of comparative genomics for the identification of MTBC-specific loci has been very limited. The few published studies focused on genetic regions acquired by horizontal gene transfer and used the limited datasets available at the time of publication, a decade ago [28] [29] [30] . By contrast, last years have witnessed a burst of available genomic sequences of a wide range of mycobacteria species and thousands of strains of the MTBC [31] [32] [33] .
In this work, we perform a large-scale comparative genomic analysis to provide a reference list of 30 MTBC-specific loci that will be of great utility for the scientific community working on the development of new research and clinical tools for tuberculosis. Remarkably, we found that the main MTBC markers used up to date are also present in other organisms, mainly NTM. In our analysis, we assess the global diversity of each MTBC-specific gene among a comprehensive dataset of more than 4,700 MTBC strains, showing the value of using the genomic data at hand to identify the best targets for diagnostic assays. In addition, we develop a qPCR assay based on one of these markers capable of quantifying MTBC DNA in clinical samples.
Methods

In silico identification of MTBC-specific diagnostic gene markers
To identify MTBC-specific loci, we used blastn[34] to look for all the genes of the tuberculosis reference strain H37Rv (NC_000962.3) in the NCBI nucleotide nonredundant database (accessed October 2018) and a custom database comprising 4,277 NTM assemblies (Supplementary Methods 1). All the searches were performed specifying the algorithm blastn with a word size (or seed) of 7 bp. Then, we filtered the results with a set of stringent parameters to discard loci similar to any genomic region of any organism other than MTBC. We discarded all the genes that presented an alignment of more than 25% of its sequence (query coverage) with a similarity greater than 80%. If a gene was aligned in 60% of its sequence or longer it was discarded regardless of the similarity of the alignment. We only kept those genes that were present in all the MTBC bacteria.
Once potential MTBC-specific markers were identified, we decided to assess their genetic diversity. To do this, we analyzed the polymorphisms (single nucleotide polymorphisms (SNPs) and indels) observed at each position across a dataset comprising 4,766 genomes of MTBC strains [35] . Therefore, the number of SNPs of each gene was calculated as the sum of positions showing any nucleotide other than the reference. In the case of indels, we considered those positions showing an indel in at least 10 strains (0.2% of the database) to avoid the noise introduced by single-strain indels spanning large genic regions and possible false deletions arising as a result of sequencings with uneven genomic coverages. This allowed us to calculate different metrics for each gene such as the absolute number of polymorphisms, polymorphisms per base and, most importantly, the prevalence of each one.
Finally, we looked for available information of these genes in the bibliography, what allowed us to discard some candidates based on their genomic context and provide extended information about their physiology. We gathered transcriptomic and proteomic data derived from different published studies: transcriptomic data in response to overexpression of 206 transcription factors [36] , different genotoxic stresses[37] and response to nitric oxide stress at different time-points [38] , as well as proteomic data in response to nutrient starvation [39] .
Set-up of a MTBC-specific qPCR assay for DNA detection and quantification
We used the list of 30 MTBC-specific loci to set up a qPCR assay for the detection and quantification of MTBC DNA. To select the target for the assay, we took into consideration the number of polymorphisms per base, the absence of high-prevalent polymorphisms, the gene length and its genomic context. These criteria enabled an optimum design of primers, amplifying a universal and highly-specific region for the detection of MTBC. We designed the primers and probes for the assay using the web tool Primer-BLAST [40] , checking that no unspecific amplicons were predicted.
Finally, the qPCR assay consisted on the amplification of a 65 bp region within the Rv2341 gene using the following primers: Forward-GCCGCTCATGCTCCTTGGAT, and 17 different species of NTM (Supplementary Methods 2).
The reaction efficiency was calculated using serial dilutions of pure H37Rv DNA as template (0.5 ng/ul to 0.5*10 -5 ng/ul). In addition, we evaluated the performance of the assay detecting and quantifying MTBC DNA in a test set of clinical samples. We used extracted DNA from 12 homogenized sputum samples from culture-positive TB patients, two of them with negative smear microscopy. We also used a DNA extraction from a non-TB patient sputum to spike in known concentrations of pure H37Rv DNA (0.5 ng/ul to 0.5*10 -5 ng/ul), to calculate the reaction efficiency in clinical samples.
All the qPCR reactions were carried out using hydrolysis probes chemistry (FAM/BHQ) in a total volume of 20ul, containing 10ul of Kapa Probe Fast Master Mix 2X (Kapa Biosystems), 250mM of each primer, 350mM of probe and 2ul of sample.
All were performed in a Roche Lightcycler 96 (Roche Diagnostics), with two replicates per sample and including reactions with no template as negative controls (NTC). When calculating reaction efficiencies, we used three replicates per point instead of two. The conditions for each assay comprised an initial denaturation step at 95ºC for 3 minutes, followed by 55 amplification cycles as follows: 20 seconds at 60ºC for annealing, 1 second at 72ºC for extension, and 10 seconds at 95ºC for denaturation. The results were analyzed with LightCycler 96 ® 1.1 software.
Triplicates of each assay were carried out to check the reproducibility. kit) and samples with a concentration higher than 1ng/ul were normalized to 1ng/ul.
In the case of the 13 sputum specimens, DNA extraction was performed as described by Votintseva et al [42] . All the samples were handled in a BSL-3 until DNA was extracted and purified.
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Results
We identified 40 genes to be uniquely present in members of the MTBC according to our filtering parameters ( Figure 1 ). After evaluating their genetic diversity across a database of more than 4,700 MTBC strains, we observed that the median number of Among these, 9 genes were discarded as potential diagnostic markers since they were included in regions of difference (RD) 182 (Rv2274c) and RD 207 (Rv2816c-Rv2820c) as described in Gagneux et al.[43] or were in variable genomic regions associated to CRISPR elements (Rv2816c-2823c) [44] . Another gene, Rv3424c was also discarded as we found it to be duplicated in a very labile genomic region, between the (putative) transposase of the insertion sequence IS1532 and PPE 59.
Therefore, the curated list of MTBC-specific diagnostic markers finally consisted in 30 genes (Figure 1) .
When looking at published transcriptomic and proteomic data (see Methods), we observed that Rv2003c, Rv2142c, and Rv3472 proteins are found in greater levels (6.19, 3.6 and 100-fold respectively) when the bacteria is subjected to starvation.
Interestingly, Rv2003c is also observed to be overexpressed upon treatment with nitric oxide (Supplementary File 2) .
primers that avoid, at the same time, any region harboring prevalent polymorphisms ( Figure 1) .
When testing the qPCR assay with a panel of samples including different MTBC lineages, human, mock bacterial communities and different NTMs, the specificity of the assay was of 100%. The efficiency of the reaction was of 95% showing a limit of detection of 10fg (hypothetically corresponding to 2 genome equivalents). When using a standard curve of pure H37Rv DNA spiked in sputum samples, both the efficiency of the reaction (97%) and the limit of detection remained unaltered ( Figure   2 ). When testing our qPCR assay with a panel of 12 TB sputum samples, we were able to detect and quantify MTBC DNA in all TB patient sputa, including 2 confirmed TB cases with a negative smear microscopy ( Supplementary File 4) . Our analysis provides invaluable information to develop such diagnostics, with a catalog of specific MTBC markers. Remarkably, some of the markers that we identify could be targeted to determine the physiological status of MTBC bacteria under certain conditions. For example, Rv2003c, overexpressed during starvation and upon treatment with nitric oxide [38, 39] , is also upregulated during dormancy [48] .
Discussion
Similarly, Rv1374c has been described to be a small RNA that is highly expressed during exponential growth [49] , and hence could be used to evaluate the replicative state of the bacilli. 
Declarations Competing Interests
The authors declare no conflict of interest in this article. 
Funding Sources
